This invention relates generally to implanted medical devices used to access subcutaneous regions within a body, such as vasculature.
Long term access to a patient's body is required for many medical treatments including antibiotic therapy, hemodialysis access, chemotherapy regimens, and other treatments that require repeated administration, withdrawal, or exchange of fluids. In some cases, internal access to the patient is required for years.
Subcutaneously implanted access ports are one type of medical device that can be used for this purpose. These medical devices often either include or are attached to a catheter used for the administration, withdrawal, and/or exchange of fluids from the patient. A pocket is made in the subcutaneous tissue, and the medic device is placed into the pocket.
Access ports generally have a molded or rigid housing, with a fixed number of suture holes. These suture holes protrude from the housing of the medical device, causing it to have a larger overall size than it otherwise would have. During implantation, a physician is thus required to create an incision in the body of sufficient size to allow insertion of the device. Further, rigid appendages on the housing of the medical device can make manipulation of the device within the body of a patient difficult for a physician.
Suturing of such a device can be performed by the physician to secure or stabilize the device. A number of factors determine whether or not the medical device is sutured in place, including the pocket configuration, the type of training received by the physician, and the physician's preference. Once the device is properly positioned and secured, the pocket is closed.
There is a wide range of preferences among physicians regarding the number and location of suture holes. Some physicians prefer one, two, three, four, or more suture holes. Some physicians prefer not to have any suture holes, and yet others prefer to have any suture holes that are present filled with a material such as silicone to minimize fibrin ingrowth into the suture holes, thereby facilitating subsequent removal of the device.
After suturing has been completed, the rigid housing of the medical device and the associated suture holes do not readily accommodate movement of the patient. Movement of the patient causes the tissue to which the medical device has been sutured to move. The rigidity of the device thus results in increased tension on the sutures, resulting in discomfort and irritation to the patient.
In one aspect, the invention features an implantable medical device for percutaneous access to a body comprising a flexible member and a housing defining an entry site for the administration, withdrawal, or exchange of fluids. The flexible member is attached to a surface of the housing and stabilizes placement of the medical device within the body. An adhesive is disposed on a first surface of the flexible member and attaches the flexible member to the housing surface. The flexible member can comprise suture locations, and the suture locations can define one or more suture holes. The suture holes can be filled with a material to minimize tissue ingrowth, such as fibrin. The material can be silicone or a biocompatible polymer, and is preferably penetrable by a suture needle.
The flexible member can have a perimeter region penetrable by a suture needle, which can be formed of materials including polyurethane, thermoplastics, elastomers, and fiber reinforced elastomers. The flexible member can also include tabs, which can be located about a perimeter of the flexible member. The tabs can define one or more suture holes.
The flexible member can be coated with a tissue growth substance and can be shaped and/or textured to conform to tissue within the body. A second surface of the flexible member can include an adhesive for attaching the device to tissue within the body. The flexible member can be preformed to mate with the housing. It can also be shaped to surround a perimeter of the housing.
Another aspect of the invention features a flexible member for stabilizing the placement of a medical device within a body. The flexible member includes a flexible substrate that mates with the medical device, one or more suture locations formed on the flexible substrate, and an adhesive. The flexible member can be formed from a material penetrable by a suture needle. Materials such as polyurethanes, thermoplastics, elastomers, and fiber-reinforced elastomers can be used to form the flexible member.
The flexible member can comprise one or more suture locations, and these can each define one or more suture holes. The suture holes can be filled with a tissue growth substance that inhibits tissue growth. The suture holes can be filled with substances such as silicone and biocompatible polymers. In one embodiment, the substance is penetrable by a suture needle.
The flexible member can also include tabs, and the tabs can be disposed about the perimeter of the flexible member. The tabs can be flexible and can be penetrable by a suture needle. The flexible member can be coated with a substance to inhibit tissue growth. It can also be preformed to mate with the perimeter of a surface of the medical device and can have a second surface shaped to conform to subcutaneous tissue within the body.
At least a portion of the perimeter of the flexible member can follow a perimeter of the surface of the medical device to which the flexible member is attached. The flexible member can include an adhesive to secure the flexible member to the medical device. The adhesive, can include methoxy-perfluoropropane, thixotropic sealants, and water-based adhesives.
Another aspect of the invention features a method of manufacturing an implantable medical device that comprises providing a housing defining an entry site for the administration, withdrawal, or exchange of fluids, and attaching a flexible member thereto, for stabilizing placement of the housing within the body. The flexible member can be formed by cutting a sheet of polymer. The method can include applying an adhesive to the flexible member by at least one of spray coating, slot coating, spiral spraying, melt-blowing, pattern coating, layering, dipping and drying, and ion deposition.
Another aspect of the invention features a method of fabricating a flexible member which includes forming a shape for mating with an implantable medical device, forming suture locations about the shape of the flexible member, and applying an adhesive to the shape. The shape can be formed by cutting from a sheet of polymer, and suture holes can be formed in the flexible member.
These and other features of the invention are more fully described below in the detailed description and accompanying drawings of which the figures illustrate an apparatus and method for securing an implantable medical device within a body.
The medical device can also include a predetermined number of suture holes 14 disposed about the base of the housing in fixed locations. The suture holes can be molded into the housing 11 as shown. A physician can tie a suture through the suture hole, thus securing the medical device 10, for example, to adjacent tissue. The medical device shown has two entry sites 12.
A flexible member 30 is attached to a surface 32 of the housing. A perimeter region 35 of the member 30 is non-rigid and flexible. When flexed, the size of the incision required for insertion of the medical device in a body can be reduced. Suture locations 38 are disposed along the perimeter region 35 of the flexible member 30.
The flexibility of the member 30 also enhances the manipulation and placement attributes of the device, providing a physician with increased capabilities and reducing aggravation and irritation to a patient. Patient recovery and comfort are thus enhanced. The flexible member also results in improved comfort and reduced irritation to the patient after the medical device has been implanted. Movement of a patient causes the tissue to which the medical device has been sutured to move. The resiliency of the flexible member thus reduces the stress to the body tissues of the patient during movement of the patient. This results in reduced irritation to the body and increased patient comfort. If sutures are present (discussed below), the benefit of this feature is increased.
The perimeter region 35 of the flexible member 30 can extend beyond the perimeter 47 of the housing surface. As shown, the perimeter region 35 of the flexible member 30 can extend beyond the perimeter of the housing surface 47 on all sides. In other embodiments, the perimeter region 35 can extend beyond the perimeter 47 of the housing surface on fewer than all sides.
Each of the embodiments found in
Referring to
The suture locations 38 can be an important element of some embodiments of the invention. In one embodiment, the suture locations 38 comprise permeable portions of the perimeter region 35 of the flexible member 30, such as a permeable membrane. For example, the suture locations in each of the embodiments described above comprising a perimeter region 35 can have one or more suture locations 38 including a permeable membrane. A permeable membrane is any biocompatible material that a physician can penetrate with a suture needle, either before or during implantation of the medical device within the body of a patient. A perimeter region 35 can comprise zero, one, or a plurality, of suture locations. Furthermore, in some embodiments the entire perimeter region 35 can be penetrable by a suture needle, and thus can function as a large suture location 38. In still other embodiments, the entire flexible member 30 can be penetrable by a suture needle.
For embodiments comprising a permeable membrane, the suture location 38 is generally made of as material that closes back about the suture or suture needle after the material has been penetrated. Suture locations such as these can be penetrated one time or multiple times by a suture needle. Generally, a physician penetrates a given point within a suture location only once with a suture needle, although the same point on a suture location can be penetrated multiple times. However, a suture location can readily be sutured multiple times by a physician if multiple sutures are to be attached to that suture location, and these sutures can be positioned at the same or different points. The suture location thus comprises a permeable membrane that can be penetrated at multiple different locations. Multiple sutures can thus be located adjacent to each other, can be scattered about the suture location 38, or can be scattered about the perimeter region 35, all at the discretion of the physician. This is a useful feature in that a physician does not have to determine before surgery if, or how many, sutures are needed, or precisely at what locations about the medical device 10 they will be placed.
The decision to attach any sutures to the medical device at all is at the discretion of the physician. Stabilization of the placement of the medical device 10 within a body using the flexible member 30, without suturing, and either with or without the presence of suture locations, represents a preferred embodiment for some physicians.
In other embodiments, suture holes 14 may be punched into suture locations 38. Suture locations 38 in each of the embodiments described above can have one or more suture holes 14. The use of suture holes 14 eliminates the need for a physician to force a suture needle through the material of the suture location 38. More than one hole may be located in a suture, location, and suture holes can be conveniently punched into the flexible member 30 before surgery using simple tools. Alternatively, suture holes 14 can be preformed at suture locations 38 about the perimeter region 35 of flexible member 30 at the time of manufacture.
In some embodiments prepunched patterns are formed, for example, in the perimeter region 35 or on the tabs 72 of the flexible member 30 to facilitate the creation of suture holes 14. Holes prepunched in this manner each have an easily removable plug, the removal of which creates suture holes 14 ready for use by a physician.
Although reference to sutures, suturing, and suture needles has been made above, the invention is equally applicable to staples, hooks, and other devices and means known to those of skill in the art for placing, securing, or attaching devices within a body. Use of the terms suture and suturing is intended to include these other devices and methods.
Furthermore, the above discussion has centered on suture locations 38 disposed within the perimeter region 35 specifically, and generally within the flexible member 30. However, the invention also includes suture locations 38 disposed within tabs 72, as discussed above. These suture locations can include suture holes 14, or not. As with the flexible member 30 and the flexible region 35, these tabs are preferably foldable and flexible.
In embodiments, the suture holes 14 can be filled with a filling material. This filling material can be added to the suture hole 14 before surgery, and preferably during manufacture of the flexible member 30. The filling material should be formed of a soft material such as silicone that can be penetrated by a suture needle, and that will close about a suture after suturing. Other materials can be used to fill the suture holes 14, such as CORETHANE® (registered mark of Corvita Corporation, Miami, Fla.), polyurethane, and bionate polycarbonate urethanes. Materials with a Durometer reading of 50-55 are preferred for this purpose. Such materials are relatively soft, and can be conveniently punctured with a needle. An appropriate material thickness should be used, as is apparent to one of ordinary skill in the art. The suture holes 14 can be filled or pre-filled with the filling material. The presence of the filling material in the suture hole 14 minimizes tissue ingrowth into the suture hole, making subsequent removal of the medical device less difficult.
Additionally the flexible member 30, and the medical device, can be coated with a material, for example, to inhibit tissue ingrowth. Suitable coatings include but are not limited to antimicrobial coatings for the prevention of microbial biofilming, hydrogel coatings, zinc oxide coatings for preventing surface irritation, various block copolymers, tackifying resins, and polybutene. The medical device and the flexible member can also be impregnated with an antimicrobial substance, preferably at least in a portion of the device that will be located near the cutaneous layer 151.
A shape corresponding to the pattern can then be cut from a polymer sheet (step 216), such as silicone. Any pre-planned suture holes 14 can next be added to the tabs 72 and the perimeter regions 35 (step 217). These, can be added, for example, by puncturing. Optionally, any suture holes 14 that have been tanned in step 217 can be filled with a substance to inhibit tissue growth into the suture hole (step 218). Finally, at the discretion of the physician, additional suture holes can be added to suture locations 38 and any unwanted tabs 72 can be severed from the flexible member, at the time of surgery (step 219).
To complete the manufacture of a medical device, a housing, such as that of an implantable port, is provided. The flexible member is then attached to a surface of the medical device. When implanted within the body, the medical device exhibits improved placement stability.
Other embodiments of the manufacturing process are also possible. For example, an adhesive coating can be applied to the flexible member after it has been cut from the polymer sheet, or the polymer sheet can comprise an adhesive material before the cutting is performed. Preferably, the adhesive is applied to the sheet of polymer material by at least one of slot coating, spiral spraying, melt blowing, pattern coating, layering, dipping/drying, and ion deposition.
Suitable biocompatible adhesives are known to those of ordinary skill in the art, and include water-based adhesives, methoxy-perfluoropropane, and thixotropic sealants. Such adhesives can be coated continuously or discontinuously, and are compatible with muscle, tissue, skin surfaces, and the like. The first surface 41 of the flexible member comprises such an adhesive, for contacting the housing surface 32. Optionally, the same or a different adhesive can be applied to the second surface 44 of the flexible member, for contacting tissue layer 154. Tissue-specific adhesives can also be used. The application of adhesive to tie second surface 44 of the flexible member contributes to the placement stabilization of the medical device 10. Adhesives of low or moderate tacking strength can also be used on either surface, to facilitate repositioning or removal of the flexible member. Preferably, the adhesive selected for this purpose will not leave a residue or exhibit any adhesive transfer to the tissue surface 154 upon removal or relocation of the medical device 10. Materials left behind after removal of the medical device can adversely affect healing of the body.
The flexible member 30 can be manufactured from many different materials. Preferably, the flexible member is formed from at least one of thermoplastics, elastomers, polyurethanes, and fiber reinforced elastomers. Suitable fibers for this purpose include polyester or Kevlar® fiber. Kevlar® is a registered trademark of E.I. duPont de Nemours and Company. The flexible member can also be manufactured from materials such as a latex/plastic polymer blend, silicone, vinyl, foam, rubbers, varying percentages of rubbery block co-polymers and midblocks comprising ethylene/propylene and ethylene/butylene, and mixtures thereof, S-EP block co-polymers (styrene-ethylene/propylene), dycyclopentadiene, fully hydrogenated aliphatic C5 and C9 resins, and alpha-methylstyrene based resins.
Various packaging and usage options are within the scope of the invention. For example, a package can be sold that includes a set of pre-cut flexible members or “frames.” The physician can then select the desired style from the set, attach it to the medical device, and perform the implantation. The package can include flexible members with, for example, a one, two or three-hole option. The physician merely selects the flexible member that meets his needs and preferences. Optionally, if desired, the medical device can be trimmed and/or suture holes can be added, before attaching a flexible member.
A linear incision is made in the patient (step 232). The incision is of reduced size, due to the planned usage of the flexible member. The flexible member can be adhesively attached to the housing surface 32 at this time (step 233), or it can be attached later. Attaching it later allows the smallest incision size to be used.
The housing 11 and the flexible member 30 are inserted through the incision, into the body of the patient, near an area in which the catheter 22 is to be placed. The physical positions the catheter, and then positions the flexible member adjacent the tissue layer 154 (step 236). The flexible member is then sutured into place (step 237). This can be done by sewing subcutaneous sutures through the suture locations 38, thereby securing the flexible member 30 to adjacent tissue. The flexible member is now attached to the housing surface 32, if it has not already been attached (step 238). The incision is then closed and bandaged (step 239).
The sutures can thus be used to anchor the tissue layer 154 and/or the cutaneous layer 151 to the medical device 10. In other embodiments tissue can be anchored the medical device using subcutaneous hooks and other devices and methods known to the skilled artisan.
In some embodiments the flexible member 30 or the housing 11 can be coated with materials that promote tissue growth to provide better sealing of the incision, such as collagen or other tissue growth catalysts and substances. Materials that promote ingrowth of cells, such as a permeable fabric, a textured polymer, or appropriate mesh materials can also be bonded to or embedded into the surface of medical device 10. The added ingrowth materials cause the skin surrounding the medical device 10 to bond securely with the medical device 10. Alternatively, growth inhibition materials can be placed on or around the medical device. For example, suture holes 14 that will not be used can be filled with silicone to prevent tissue ingrowth. Thus, fibrin will not grow into these suture locations, and the medical device can later be more easily removed.
The flexible member of the invention is suitable for use with various medical devices including implantable venous ports, PEG ports, and other epidermal and indwelling medical devices that, for example, provide access to the body or to vasculature. These include devices used for gastrointestinal feeding and metering, intervascular pumps, insulin pumps, drainage products (such as for draining an abscess), pacing products (such as pacemakers), and various catheters.
While the invention has been particularly shown and described with reference to specific preferred embodiments, it should be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
3094124 | Birtwell | Jun 1963 | A |
3438375 | Ericson | Apr 1969 | A |
3971376 | Wichterle | Jul 1976 | A |
3978157 | Bottenbruch et al. | Aug 1976 | A |
4054139 | Crossley | Oct 1977 | A |
4142525 | Binard et al. | Mar 1979 | A |
4245635 | Kontos | Jan 1981 | A |
4248224 | Jones | Feb 1981 | A |
4309994 | Grunwald | Jan 1982 | A |
4403983 | Edelman et al. | Sep 1983 | A |
4405305 | Stephen et al. | Sep 1983 | A |
4423740 | Castle et al. | Jan 1984 | A |
4425119 | Berglund | Jan 1984 | A |
4468224 | Enzmann et al. | Aug 1984 | A |
4469483 | Becker et al. | Sep 1984 | A |
4483688 | Akiyama | Nov 1984 | A |
4543088 | Bootman et al. | Sep 1985 | A |
4563180 | Jervis et al. | Jan 1986 | A |
4569673 | Tesi | Feb 1986 | A |
4571749 | Fischell | Feb 1986 | A |
4587954 | Haber | May 1986 | A |
4592920 | Murtfeldt | Jun 1986 | A |
4603152 | Laurin et al. | Jul 1986 | A |
4623327 | Mahurkar | Nov 1986 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4673394 | Fenton, Jr. et al. | Jun 1987 | A |
4692146 | Hilger | Sep 1987 | A |
4710174 | Moden et al. | Dec 1987 | A |
4767410 | Moden et al. | Aug 1988 | A |
4769005 | Ginsburg et al. | Sep 1988 | A |
4778452 | Moden et al. | Oct 1988 | A |
4781680 | Redmond et al. | Nov 1988 | A |
4781695 | Dalton | Nov 1988 | A |
4804359 | Grunwald et al. | Feb 1989 | A |
4808156 | Dean | Feb 1989 | A |
4822341 | Colone | Apr 1989 | A |
4838873 | Landskron et al. | Jun 1989 | A |
4857053 | Dalton | Aug 1989 | A |
4886501 | Johnston et al. | Dec 1989 | A |
4886502 | Poirier et al. | Dec 1989 | A |
4892518 | Cupp et al. | Jan 1990 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4902503 | Umemura et al. | Feb 1990 | A |
4929236 | Sampson | May 1990 | A |
4944726 | Hilal et al. | Jul 1990 | A |
4954130 | Edwards | Sep 1990 | A |
4955861 | Enegren et al. | Sep 1990 | A |
4966586 | Vaillancourt | Oct 1990 | A |
4983162 | Metais et al. | Jan 1991 | A |
5013304 | Russell et al. | May 1991 | A |
5019096 | Fox, Jr. et al. | May 1991 | A |
5041098 | Loiterman et al. | Aug 1991 | A |
5053013 | Ensminger et al. | Oct 1991 | A |
5059170 | Cameron | Oct 1991 | A |
5069206 | Crosbie | Dec 1991 | A |
5084015 | Moriuchi | Jan 1992 | A |
5092849 | Sampson | Mar 1992 | A |
5125893 | Dryden | Jun 1992 | A |
5129891 | Young | Jul 1992 | A |
5133742 | Pinchuk | Jul 1992 | A |
5137529 | Watson | Aug 1992 | A |
5151231 | Lambert et al. | Sep 1992 | A |
5167638 | Felix et al. | Dec 1992 | A |
5171305 | Schickling et al. | Dec 1992 | A |
5178612 | Fenton, Jr. | Jan 1993 | A |
5180365 | Ensminger et al. | Jan 1993 | A |
5203771 | Melker et al. | Apr 1993 | A |
5205834 | Moorehead et al. | Apr 1993 | A |
5213574 | Tucker | May 1993 | A |
D337637 | Tucker | Jul 1993 | S |
5229431 | Pinchuk | Jul 1993 | A |
5236417 | Wallis | Aug 1993 | A |
5242415 | Kantrowitz et al. | Sep 1993 | A |
5249598 | Schmidt | Oct 1993 | A |
5250038 | Melker et al. | Oct 1993 | A |
5263930 | Ensminger | Nov 1993 | A |
5281199 | Ensminger et al. | Jan 1994 | A |
5281205 | McPherson | Jan 1994 | A |
5300048 | Drewes, Jr. et al. | Apr 1994 | A |
5312337 | Flaherty et al. | May 1994 | A |
5318545 | Tucker | Jun 1994 | A |
5330449 | Prichard et al. | Jul 1994 | A |
5350360 | Ensminger et al. | Sep 1994 | A |
5352204 | Ensminger | Oct 1994 | A |
5356381 | Ensminger et al. | Oct 1994 | A |
5370624 | Edwards et al. | Dec 1994 | A |
5372582 | Skrabal et al. | Dec 1994 | A |
5373855 | Skrabal et al. | Dec 1994 | A |
5387192 | Glantz et al. | Feb 1995 | A |
5399168 | Wadsworth, Jr. et al. | Mar 1995 | A |
5403291 | Abrahamson | Apr 1995 | A |
5405340 | Fageol et al. | Apr 1995 | A |
5417656 | Ensminger et al. | May 1995 | A |
5421814 | Geary | Jun 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5458582 | Nakao | Oct 1995 | A |
5476451 | Ensminger et al. | Dec 1995 | A |
5509897 | Twardowski et al. | Apr 1996 | A |
5520632 | Leveen et al. | May 1996 | A |
5520643 | Ensminger et al. | May 1996 | A |
5527277 | Ensminger et al. | Jun 1996 | A |
5527278 | Ensminger et al. | Jun 1996 | A |
5527307 | Srisathapat et al. | Jun 1996 | A |
5531684 | Ensminger et al. | Jul 1996 | A |
5542923 | Ensminger et al. | Aug 1996 | A |
5542937 | Chee et al. | Aug 1996 | A |
5549576 | Patterson et al. | Aug 1996 | A |
5554117 | Ensminger et al. | Sep 1996 | A |
5556381 | Ensminger et al. | Sep 1996 | A |
5558641 | Glantz et al. | Sep 1996 | A |
5562617 | Finch, Jr. et al. | Oct 1996 | A |
5562618 | Cai et al. | Oct 1996 | A |
5569182 | Twardowski et al. | Oct 1996 | A |
5575769 | Vaillancourt | Nov 1996 | A |
5607393 | Ensminger et al. | Mar 1997 | A |
5613945 | Cai et al. | Mar 1997 | A |
5613974 | Andreas et al. | Mar 1997 | A |
5614136 | Pepin et al. | Mar 1997 | A |
5647859 | Lampropoulos et al. | Jul 1997 | A |
RE35601 | Eckenhoff | Sep 1997 | E |
5662616 | Bousquet | Sep 1997 | A |
5662913 | Capelli | Sep 1997 | A |
5676656 | Brimhall | Oct 1997 | A |
5681289 | Wilcox et al. | Oct 1997 | A |
5695490 | Flaherty et al. | Dec 1997 | A |
5702363 | Flaherty | Dec 1997 | A |
5704915 | Melsky et al. | Jan 1998 | A |
5713844 | Peyman | Feb 1998 | A |
5723718 | Berens | Mar 1998 | A |
5725510 | Hartmann et al. | Mar 1998 | A |
5741228 | Lambrecht et al. | Apr 1998 | A |
5776096 | Fields | Jul 1998 | A |
5792104 | Speckman | Aug 1998 | A |
5792123 | Ensminger | Aug 1998 | A |
5797886 | Roth et al. | Aug 1998 | A |
5800414 | Cazal | Sep 1998 | A |
5810776 | Bacich et al. | Sep 1998 | A |
5810789 | Powers et al. | Sep 1998 | A |
5830172 | Leveen et al. | Nov 1998 | A |
5830196 | Hicks | Nov 1998 | A |
5833654 | Powers et al. | Nov 1998 | A |
5836935 | Ashton et al. | Nov 1998 | A |
5840063 | Flaherty | Nov 1998 | A |
5876366 | Dykstra et al. | Mar 1999 | A |
5879322 | Lattin et al. | Mar 1999 | A |
5879333 | Smith | Mar 1999 | A |
5879499 | Corvi | Mar 1999 | A |
5882341 | Bousquet | Mar 1999 | A |
5906596 | Tallarida | May 1999 | A |
5928174 | Gibbins | Jul 1999 | A |
5944688 | Lois | Aug 1999 | A |
5951512 | Dalton | Sep 1999 | A |
5954691 | Prosl | Sep 1999 | A |
5957890 | Mann et al. | Sep 1999 | A |
5967490 | Pike | Oct 1999 | A |
5989216 | Johnson et al. | Nov 1999 | A |
6001079 | Pourchez | Dec 1999 | A |
6001080 | Kuracina et al. | Dec 1999 | A |
6033393 | Balbierz et al. | Mar 2000 | A |
6086555 | Eliasen | Jul 2000 | A |
6093180 | Elsberry | Jul 2000 | A |
6099508 | Bousquet | Aug 2000 | A |
6102884 | Squitieri | Aug 2000 | A |
6120492 | Finch et al. | Sep 2000 | A |
6132416 | Broselow | Oct 2000 | A |
6177522 | Brady et al. | Jan 2001 | B1 |
6197845 | Janssen et al. | Mar 2001 | B1 |
6197846 | Combe et al. | Mar 2001 | B1 |
6200338 | Solomon et al. | Mar 2001 | B1 |
6213973 | Eliasen et al. | Apr 2001 | B1 |
6217566 | Ju et al. | Apr 2001 | B1 |
6227200 | Crump et al. | May 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6245039 | Brugger et al. | Jun 2001 | B1 |
6280423 | Davey et al. | Aug 2001 | B1 |
6355020 | Bousquet | Mar 2002 | B1 |
6355858 | Gibbins | Mar 2002 | B1 |
6368658 | Schwarz et al. | Apr 2002 | B1 |
6375637 | Campbell et al. | Apr 2002 | B1 |
6387105 | Gifford, III et al. | May 2002 | B1 |
6409700 | Siegel, Jr. et al. | Jun 2002 | B1 |
6419643 | Shimada et al. | Jul 2002 | B1 |
6428513 | Abrahamson | Aug 2002 | B1 |
6442415 | Bis et al. | Aug 2002 | B1 |
6446671 | Armenia et al. | Sep 2002 | B2 |
8574204 | Bourne | Nov 2013 | B2 |
9168365 | Bourne | Oct 2015 | B2 |
20010016717 | Haarala et al. | Aug 2001 | A1 |
20010056266 | Tallarida et al. | Dec 2001 | A1 |
20020082559 | Chang et al. | Jun 2002 | A1 |
20020091362 | Maginot et al. | Jul 2002 | A1 |
20020138068 | Watson et al. | Sep 2002 | A1 |
Number | Date | Country |
---|---|---|
WO9818506 | May 1998 | WO |
Entry |
---|
McCarthy, et al, The Use of a Flow Rate Injctor for Contrast-Enhanced CT, Radiology, 1984, 151:800. |
Ireland, et al, Safety and Convenience of a Mechanical Injector Pump for Conorary Angiography, Catheterization and Cardiovascular Diagnosis, 1989, 16:199-201. |
Miles, et al, Safe use of an Intravenous Power Injector for CT: Experience and Protocol, RSNA, 1990, pp. 69-70. |
Carlson, et al, Safety Considerations in the Power Injection of Contrast Media Via Central Venous Catheters During Computed Tomographic Examinations, Investigative Radiology vol. 27, 1992, pp. 337-340. |
Steinbach, et al, Breast Implants, Common Complications, and Concurrent Breast Disease, RadioGraphics 1993, 13:95-118. |
Vergara, Adverse Reactions to Contrast Media in CT: Effects of Temperature and Ionic Property, Radiology 1996, 199:363-366. |
Herts, et al, Power Injection of Contrast Material through Central Venous Catheters for CT: In Vitro Evaluation, Radiology 1996, 200:731-735. |
Kaste, et al, Safe Use of Power Injectors with Central and Peripheral Venous Access Devices for Pediatric CT, Pediatr Radiol, 1996, 36:499-501. |
Urquiola, et al, Using Lead Foil as a Radiopaque Marker for Computerized Tomography Imaging when Implant Treatment Planning, Journal of Prosthetic Dentistry vol. 77 No. 2, 1997, pp. 227-228. |
Hills, et al, Experience with 100 Consecutive Central Venous Access Arm Ports Placed by Interventional Radiologists, JVIR 1997, 8:983-989. |
Ruess, et al, In-line Pressures Generated in Small-Bore Central Venous Catheters During Power Injection of CT Contrast Media, Radiology 1997, 203:625-629. |
Herzig, et al, The Use of Power Injection with Radiographic Contrast Media Into PICC Lines, JVIR, vol. 11 Issue 2 Supp. pp. 1-535. |
Blot, et al, Accuracy of Totally Implanted ports, tunnelled, single and multiple-lumen contral venous catheters for measurement of central venous pressure, Intensive Care Med, 2000, pp. 1837-1842. |
Herts, et al, Power Injection of Contrast Media Using CVC: Feasibility, Safety, and Efficacy, AJR: 176, pp. 447-453. |
Biffi, et al, A Randomized, Prospective Trial of Central Venous Ports Connected to Standard Open-Ended or Groshong Catheters in Adult Oncology Patients, American Cancer Society, 2001, pp. 1204-1212. |
User Manual for the ESPrit 3G Speech Processor and Accessories, Nucleus Cochlear Implant Systems. |
Salis, et al, Can PICC be Used for Contrast Injection with a CT Power Injector, JVIR vol. 13, Issue 2, Supp S1-S117. |
Funaki, Central Venous Access: A Primer for the Diagnostic Radiologist, AJR: 179, 2002, pp. 309-318. |
Number | Date | Country | |
---|---|---|---|
20160001055 A1 | Jan 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14070134 | Nov 2013 | US |
Child | 14856680 | US | |
Parent | 10277215 | Oct 2002 | US |
Child | 14070134 | US |